Yuhan Corporation
KSC: 000105.KS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Korea Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Wook-Je Cho
- Employees
- 1,999
- Headquarters
- Seoul, South Korea
- IPO year
- 2005
- Market cap
- ₩5.5T
- Website
- https://www.yuhan.co.kr
Loading 000105…
Loading profile data…Frequently asked questions about 000105
What does Yuhan Corporation (000105.KS) do?
Yuhan Corporation, a pharmaceutical company, engages in the research, development, and production of active pharmaceutical products and intermediates in South Korea and internationally. It offers antivirals, antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds; Revanex, an acid pump an...
Where does 000105.KS trade?
Yuhan Corporation (000105.KS) trades on the Korea Exchange.
What sector is 000105.KS in?
Yuhan Corporation (000105.KS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Yuhan Corporation?
Wook-Je Cho is the chief executive officer of Yuhan Corporation (000105.KS).
Where is Yuhan Corporation headquartered?
Yuhan Corporation is headquartered in South Korea.
Does 000105.KS pay a dividend?
Yes — Yuhan Corporation (000105.KS) paid a trailing twelve-month dividend of KRW 610.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 000105.KS go public?
Yuhan Corporation (000105.KS) completed its initial public offering in 2005.